Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (6652)	5/11/1999 10:07:00 AM
From: Linda Kaplan	Respond to of 7041

Love that image and I think it's suitable. But what makes you think that there WILL be a reapplication? Let me dust off my crystal ball for you... First there will be delays and more delays. Then in a year or so they will say that the new tests didn't turn out as they'd hoped. Ooops! No reapplication in the US. Since they were saving their advertising for the US, not to waste it on Mexico or Brazil, it won't cost SGP more money then it has already cost them. Linda

To: Hank who wrote (6652)	5/11/1999 10:07:00 AM
From: Dauntless	Read Replies (2) \| Respond to of 7041

Thanks Hank <<You can't even admit defeat after both of your legs and arms have been chopped off>> Interesting that you would call this pathetic. I kind of enjoy that reputation - but I'm wasting my breath on you. TRY to understand this - until the FDA has "rejected" this drug and/or SGP & Zona announce that they have ceased working on an approval - there has been no conclusion. If and when that happens, I WILL admit that I was wrong about the approval of Vasomax - publicly, just like a noble Knight.